MEI Pharma Inc (MEIP) Stock

DelistedNasdaq: MEIPMEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

3.07
Final close · Sep 10, 2025

MEIP is no longer traded. MEI Pharma was delisted from the Nasdaq in September 2025.

Prices on this page are historical; the last trade was September 10, 2025 at $3.07.

MEI Pharma stock price history

Split-adjusted closes, 2003–2025

MEIP final trading statistics

Final close
$3.07
Final trading day
Sep 10, 2025
Market cap at delisting
$100.81M
Shares outstanding
32.84M
Final 52-week range
$1.46 – $9.00
Avg. volume (final 3 mo.)
1,434,193
All-time high (split-adj.)
$11903.46 · Feb 2004
All-time low (split-adj.)
$1.86 · Apr 2025
Return since IPO
-100.0%
Beta
0.22
Book value / share
$2.93
Price / book
1.05
Final 52 wk
1.469.00

MEI Pharma adjusted earnings per share

Adjusted EPS

MEI Pharma revenue & net income

RevenueNet income

MEI Pharma annual financials

MEI Pharma Inc revenue, net income and adjusted EPS by fiscal year
Fiscal yearRevenueNet incomeAdj. EPS
FY2025$0.00-$15.9M—
FY2024$65.30M$17.8M$2.67
FY2023$48.82M-$31.8M-$3.87
FY2022$40.70M-$54.5M-$0.35
FY2021$25.54M-$41.3M-$0.45

Last five fiscal years reported before the delisting; fiscal year ending June. Adj. EPS is adjusted (non-GAAP) earnings per share as reported by the company, so it can differ from net income per share and can be positive in a year with a net loss. Source: company filings via EODHD.

About MEI Pharma Inc

MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

MEI Pharma stock FAQ

What happened to MEI Pharma stock?

MEI Pharma stock was delisted from the Nasdaq. Its final close was $3.07 on September 10, 2025.

Is MEIP stock still trading?

No. MEIP was delisted from the Nasdaq in September 2025 and no longer trades on a U.S. exchange.

What was the last price of MEIP stock?

MEIP closed at $3.07 on its final trading day, September 10, 2025, for a market value of about $100.81M.

What were MEI Pharma's revenue and earnings in its last full fiscal year?

MEI Pharma reported revenue of $0.00 and net income of -$15.9M in fiscal 2025, its last full year as a public company.

When did MEI Pharma go public?

MEI Pharma Inc stock began trading on December 19, 2003.

Biotechnology stocks to research

All Healthcare stocks →